免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)

NCT:NCT07712666 · NOT_YET_RECRUITING

NCT编号NCT07712666
状态NOT_YET_RECRUITING
开始日期2026-11-01
完成时间2029-08-01
SponsorMayo Clinic (OTHER)
First posted
Last updated

简要摘要

The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑